These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18284001)

  • 41. Comparison of equal doses of continuous venovenous haemofiltration and haemodiafiltration on ciprofloxacin population pharmacokinetics in critically ill patients.
    Roger C; Wallis SC; Louart B; Lefrant JY; Lipman J; Muller L; Roberts JA
    J Antimicrob Chemother; 2016 Jun; 71(6):1643-50. PubMed ID: 26957490
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Population pharmacokinetics and dose simulation of vancomycin in critically ill patients during high-volume haemofiltration.
    Escobar L; Andresen M; Downey P; Gai MN; Regueira T; Bórquez T; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Aug; 44(2):163-7. PubMed ID: 24837847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure.
    Saudan P; Niederberger M; De Seigneux S; Romand J; Pugin J; Perneger T; Martin PY
    Kidney Int; 2006 Oct; 70(7):1312-7. PubMed ID: 16850022
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients.
    Bugge JF
    Acta Anaesthesiol Scand; 2001 Sep; 45(8):929-34. PubMed ID: 11576041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elimination of levofloxacin in critically ill patients with renal failure: influence of continuous veno-venous hemofiltration.
    Bellmann R; Egger P; Gritsch W; Bellmann-Weiler R; Joannidis M; Dunzendorfer S; Wiedermann CJ
    Int J Clin Pharmacol Ther; 2002 Apr; 40(4):142-9. PubMed ID: 11996208
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
    Muhl E; Martens T; Iven H; Rob P; Bruch HP
    Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients.
    Chaijamorn W; Jitsurong A; Wiwattanawongsa K; Wanakamanee U; Dandecha P
    Int J Antimicrob Agents; 2011 Aug; 38(2):152-6. PubMed ID: 21636256
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of pathophysiology on pharmacokinetics in the critically ill patient--concepts appraised by the example of antimicrobial agents.
    Blot SI; Pea F; Lipman J
    Adv Drug Deliv Rev; 2014 Nov; 77():3-11. PubMed ID: 25038549
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic effects of continuous veno-venous haemofiltration in critically ill patients.
    Sorkine P; Halpern P; Scarlat A; Weinbroum A; Silbiger A; Setton A; Rudick V
    Clin Intensive Care; 1994; 5(6):293-5. PubMed ID: 10150557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inadequate antibiotic dosing in patients receiving sustained low efficiency dialysis.
    Keough LA; Krauss A; Hudson JQ
    Int J Clin Pharm; 2018 Oct; 40(5):1250-1256. PubMed ID: 30051232
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Multiple-dose pharmacokinetics of daptomycin during continuous venovenous haemodiafiltration.
    Wenisch JM; Meyer B; Fuhrmann V; Saria K; Zuba C; Dittrich P; Thalhammer F
    J Antimicrob Chemother; 2012 Apr; 67(4):977-83. PubMed ID: 22210754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapeutic drug monitoring of antitubercular agents for disseminated Mycobacterium tuberculosis during intermittent haemodialysis and continuous venovenous haemofiltration.
    Sin JH; Elshaboury RH; Hurtado RM; Letourneau AR; Gandhi RG
    J Clin Pharm Ther; 2018 Apr; 43(2):291-295. PubMed ID: 28895161
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A; Gascón AR; Maynar J; Arzuaga A; Toral D; Pedraz JL
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pilot Study of the Pharmacokinetics of Cefotaxime in Critically Ill Patients with Acute Kidney Injury Treated with Continuous Renal Replacement Therapy.
    Koedijk JB; Valk-Swinkels CG; Rijpstra TA; Touw DJ; Mulder PG; van der Voort PH; van 't Veer NE; van der Meer NJ
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3587-90. PubMed ID: 27021325
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fluid overload before continuous hemofiltration and survival in critically ill children: a retrospective analysis.
    Foland JA; Fortenberry JD; Warshaw BL; Pettignano R; Merritt RK; Heard ML; Rogers K; Reid C; Tanner AJ; Easley KA
    Crit Care Med; 2004 Aug; 32(8):1771-6. PubMed ID: 15286557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elimination of the piperacillin/tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure.
    Valtonen M; Tiula E; Takkunen O; Backman JT; Neuvonen PJ
    J Antimicrob Chemother; 2001 Dec; 48(6):881-5. PubMed ID: 11733473
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Continuous Venovenous Hemofiltration (CVVH) Versus Conventional Treatment for Acute Severe Hypernatremia in Critically Ill Patients: A Retrospective Study.
    Ma F; Bai M; Li Y; Yu Y; Liu Y; Zhou M; Li L; Jing R; Zhao L; He L; Li R; Huang C; Wang H; Sun S
    Shock; 2015 Nov; 44(5):445-51. PubMed ID: 26473438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Renal Function Estimation Formulas Specific to Dynamic Renal Function for Drug Dosing in Critically Ill Patients.
    Xiong L; Lu ZK; Quidley AM; Alford BS; Bookstaver PB
    South Med J; 2018 May; 111(5):299-306. PubMed ID: 29767223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacokinetics of ciprofloxacin in ICU patients on continuous veno-venous haemodiafiltration.
    Wallis SC; Mullany DV; Lipman J; Rickard CM; Daley PJ
    Intensive Care Med; 2001 Apr; 27(4):665-72. PubMed ID: 11398692
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Continuous venovenous hemofiltration: an alternative to continuous arteriovenous hemofiltration and hemodiafiltration in acute renal failure.
    Macias WL; Mueller BA; Scarim SK; Robinson M; Rudy DW
    Am J Kidney Dis; 1991 Oct; 18(4):451-8. PubMed ID: 1928064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.